Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Instruments Permit Drug Developers to Characterize Polymer Solutions

By LabMedica International staff writers
Posted on 30 Aug 2011
Drug development laboratories have come to depend on advanced instrumentation that permits precise determination of polymer molecular weight distribution and other characteristics such as zeta potential.

The drug development laboratory in the department of bioengineering at the University of Pittsburgh (PA, USA) is an example of such an institution. More...
Among other projects, the investigators are synthesizing new polymers to control the release of growth factors that regulate cell activity and body function. Towards this end, they depend heavily on Malvern Instruments’ (Malvern, United Kingdom) Viscotek gel permeation system and Zetasizer Nano.

Gel Permeation Chromatography (GPC), also known as Size-Exclusion Chromatography (SEC), is a chromatographic technique that employs specialized columns to separate natural and synthetic polymers, biopolymers, proteins, or nanoparticles based on size. As the sample is separated and elutes from the column, it can be characterized by a single concentration detector or series of detectors. When the GPC/SEC separation is coupled with light scattering, viscometer, and concentration detectors together (triple detection), it will provide a distribution of absolute molecular weight, molecular size, and intrinsic viscosity as well as information on macromolecular structure, conformation aggregation and branching.

The Zetasizer Nano allows determination of other physical attributes of polymer solutions by measuring particle and molecular size from below a nanometer to several microns, zeta potential, electrophoretic mobility, and molecular weight.

“GPC is fundamental to our research,” said Hunghao Chu, a researcher in the bioengineering department at the University of Pittsburgh. “We have to fully understand our new polymers and GPC delivers absolute molecular weight measurement. We also need to know the polydispersity index of our samples to understand polymer homogeneity. When publishing data in peer reviewed journals it is very important to have confidence in results and to be able to validate them.”

“I am 100% satisfied with Malvern Instruments’ customer service,” said Hunghao Chu. “While many instruments on the market appear to provide similar standards of data, good customer service is a highly important distinction. Malvern Instruments stands out in its provision of support beyond initial purchase. This means that we can be confident in the long term functionality of any system we buy from them.”

Related Links:
University of Pittsburgh
Malvern Instruments


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.